Correlation Between Roivant Sciences and Reviva Pharmaceuticals

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Roivant Sciences and Reviva Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Roivant Sciences and Reviva Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Roivant Sciences and Reviva Pharmaceuticals Holdings, you can compare the effects of market volatilities on Roivant Sciences and Reviva Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Roivant Sciences with a short position of Reviva Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Roivant Sciences and Reviva Pharmaceuticals.

Diversification Opportunities for Roivant Sciences and Reviva Pharmaceuticals

0.13
  Correlation Coefficient

Average diversification

The 3 months correlation between Roivant and Reviva is 0.13. Overlapping area represents the amount of risk that can be diversified away by holding Roivant Sciences and Reviva Pharmaceuticals Holding in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Reviva Pharmaceuticals and Roivant Sciences is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Roivant Sciences are associated (or correlated) with Reviva Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Reviva Pharmaceuticals has no effect on the direction of Roivant Sciences i.e., Roivant Sciences and Reviva Pharmaceuticals go up and down completely randomly.

Pair Corralation between Roivant Sciences and Reviva Pharmaceuticals

Given the investment horizon of 90 days Roivant Sciences is expected to generate 12.8 times less return on investment than Reviva Pharmaceuticals. But when comparing it to its historical volatility, Roivant Sciences is 8.21 times less risky than Reviva Pharmaceuticals. It trades about 0.15 of its potential returns per unit of risk. Reviva Pharmaceuticals Holdings is currently generating about 0.24 of returns per unit of risk over similar time horizon. If you would invest  9.80  in Reviva Pharmaceuticals Holdings on August 29, 2024 and sell it today you would earn a total of  9.20  from holding Reviva Pharmaceuticals Holdings or generate 93.88% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Roivant Sciences  vs.  Reviva Pharmaceuticals Holding

 Performance 
       Timeline  
Roivant Sciences 

Risk-Adjusted Performance

4 of 100

 
Weak
 
Strong
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in Roivant Sciences are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. In spite of fairly weak forward indicators, Roivant Sciences may actually be approaching a critical reversion point that can send shares even higher in December 2024.
Reviva Pharmaceuticals 

Risk-Adjusted Performance

11 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Reviva Pharmaceuticals Holdings are ranked lower than 11 (%) of all global equities and portfolios over the last 90 days. In spite of fairly inconsistent technical indicators, Reviva Pharmaceuticals showed solid returns over the last few months and may actually be approaching a breakup point.

Roivant Sciences and Reviva Pharmaceuticals Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Roivant Sciences and Reviva Pharmaceuticals

The main advantage of trading using opposite Roivant Sciences and Reviva Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Roivant Sciences position performs unexpectedly, Reviva Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Reviva Pharmaceuticals will offset losses from the drop in Reviva Pharmaceuticals' long position.
The idea behind Roivant Sciences and Reviva Pharmaceuticals Holdings pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Instant Ratings module to determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance.

Other Complementary Tools

Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings